MED9 anticorps (C-Term)
-
- Antigène Voir toutes MED9 Anticorps
- MED9 (Mediator Complex Subunit 9 (MED9))
-
Épitope
- AA 106-136, C-Term
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp MED9 est non-conjugé
-
Application
- Western Blotting (WB), ELISA
- Réactivité croisée
- Humain, Souris
- Réactivité croisée (Details)
- Calculated cross reactivity: Hu Mo
- Attributs du produit
- MED9, CT (MED9, MED25, Mediator of RNA polymerase II transcription subunit 9, Mediator complex subunit 9)
- Purification
- Purified by Protein A affinity chromatography.
- Immunogène
- MED9 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 106-136 amino acids from the C-terminal region of human MED9.
- Isotype
- IgG
- Top Product
- Discover our top product MED9 Anticorps primaire
-
-
- Indications d'application
- Optimal working conditions should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- -20°C
-
- Antigène
- MED9 (Mediator Complex Subunit 9 (MED9))
- Autre désignation
- MED9 (MED9 Produits)
- Synonymes
- anticorps MED25, anticorps BC019367, anticorps Med25, anticorps mediator complex subunit 9, anticorps mediator complex subunit 9 L homeolog, anticorps MED9, anticorps med9.L, anticorps Med9
- NCBI Accession
- NP_060489
- UniProt
- Q9NWA0
- Pathways
- Regulation of Lipid Metabolism by PPARalpha
-